BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The 2nd Gene Therapy Potency Summit is returning to Boston in 
 July to support you in designing and validating robust potency assays to 
 accelerate commercialization across a range of vector types and delivery 
 modalities.\n\nFeaturing a speaker faculty of over 27 industry-leading ex
 perts from key biotech and pharmaceutical companies\, this summit offers 
 the most comprehensive agenda to date.\n\nFrom case studies on phase-appr
 opriate assay development to novel data presentations on cutting-edge HPL
 C and mass-spectrometry-based approaches\, this year's program covers uni
 que and diverse challenges that potency poses for complex gene therapies.
 \n\nUniting 100+ potency assay developers and solution providers from the
  likes of Sarepta Therapeutics\, Ultragenyx\, Sanofi\, Spark Therapeutics
 \, Vertex\, Sangamo Therapeutics\, and many others\, this is your critica
 l chance to learn from companies working on gene therapies from early dev
 elopment through to commercialized products.\n\nJoin us in July to engage
  with critical decision-makers\, stay on top of industry trends\, and gai
 n key insights on ways to build out a solid potency strategy to ultimatel
 y prove to regulators that your product is efficacious.\n\nURLs:Tickets: 
 https://go.evvnt.com/2239928-2?pid=185Brochure: https://go.evvnt.com/2239
 928-3?pid=185\n\nTime: 9:00 AM - 5:30 PM\n\nSpeakers: Adnan Arnaout Senio
 r Principal Scientist\, Prevail Therapeutics\, Alec Knapp Scientist\, Tun
 e Therapeutics\, David Schwalb\, Director - Analytical Development\, Cell
  and Gene Therapies\, Pacira Biosciences\, Geeta Iyer\, PD Manager\, Assa
 y Development\, Beacon Therapeutics\, Georgios Tsouchnikas\, Head Of Assa
 y Development\, Hookipa Pharma Inc.\, Gillian Payne\, Vice President - An
 alytical Development\, Carbon Biosciences\, Haiqing Yu\, Senior Scientist
  and Analytical Team Manager\, Sanofi\, Hangtian Song\, Associate Scienti
 fic Director\, Bristol Myers Squibb\, Hesham Nawar\, Director - Analytica
 l Development\, Spark Therapeutics\, Hwan June\, Kang Senior Scientist\, 
 Neurocrine Biosciences\, Isaac Hutchinson\, Tech Transfer Specialist\, Jo
 hnson and Johnson\, Jie Li\, Director\, Vertex Pharmaceuticals\, Katherin
 e Bonnington\, Scientist\, Bristol Myers Squibb\, Kayla Shumate\, Scienti
 st II\, Bioanalysis and Bioassays\, AskBio\, Natalie Fekete Manager\, Sci
 ence and Industry Affairs\, Alliance for Regenerative Medicine\, Nicola C
 rawford\, Director of Analytical Sciences\, Barinthus Biotherapeutics\, P
 ing Carlson\, Director of Bioassay\, Passage Bio\, Qian Zhang\, Scientist
 \, Sangamo Therapeutics\, Rajeev Boregowda\, Associate Director\, Bioassa
 y and Molecular Analytical Development\, Sanofi\, Sangeet Lal\, Senior Ma
 nager\, Cell-Based Potency Assay Development\, 4D Molecular Therapeutics\
 , Susan Rutberg\, Director - Bioassays and Molecular Biology\, Sanofi\, S
 usan Sleep\, Director - Assay Development\, Beacon Therapeutics\, Ting He
 \, Senior Scientist\, AAV Pharmaceutical Development\, Ultragenyx Pharmac
 eutical\, Uditha DeAlwis Director – An\,al Development and Quality Contro
 l\, Sarepta Therapeutics\, Xiaodong Fang\, Director\, Bioanalysis and Bio
 assays\, AskBio\, Youngmee Sul\, Scientist\, Tune Therapeutics\n
DTEND:20240718T173000
DTSTAMP:20260512T220339Z
DTSTART:20240716T090000
LOCATION:The Colonnade Hotel\, 120\, Huntington Avenue\, Boston\, Massachu
 setts\, 02116\,
SEQUENCE:0
SUMMARY:The 2nd Gene Therapy Potency Summit is returning to Boston in July
  to support you in designing and validating robust potency assays to acce
 lerate c...
UID:2139b266-1cdf-4e73-ba03-4e494ca6f33b
END:VEVENT
END:VCALENDAR